These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6266823)

  • 1. Adverse effects of phenytoin on peripheral nerves and neuromuscular junction: a review.
    So EL; Penry JK
    Epilepsia; 1981 Aug; 22(4):467-73. PubMed ID: 6266823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The site and mode of action of propanidid on the peripheral motor unit.
    Ellis FR
    Anaesthesist; 1971 Jan; 20(1):19-22. PubMed ID: 4322995
    [No Abstract]   [Full Text] [Related]  

  • 3. [Carbon tetrachloride in its effects on peripheral nerves (experimental study on rabbits)].
    Glatzel W; Grünes JW; Tietze K
    Z Gesamte Inn Med; 1970 Jul; 25(13):600-1. PubMed ID: 4331693
    [No Abstract]   [Full Text] [Related]  

  • 4. Anticonvulsant therapy and its possible consequences on peripheral nervous system: a neurographic study.
    Geraldini C; Faedda MT; Sideri G
    Epilepsia; 1984 Aug; 25(4):502-5. PubMed ID: 6086303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral nerve function in long-term therapy with diphenylhydantoin. A clinical and electrophysiologic correlation.
    Eisen AA; Woods JF; Sherwin AL
    Neurology; 1974 May; 24(5):411-7. PubMed ID: 4363815
    [No Abstract]   [Full Text] [Related]  

  • 6. Peripheral neuropathy in children on long-term phenytoin therapy.
    Mochizuki Y; Suyehiro Y; Tanizawa A; Ohkubo H; Motomura T
    Brain Dev; 1981; 3(4):375-83. PubMed ID: 6274215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticonvulsant peripheral neuropathy: a clinical and electrophysiological study of patients on single drug treatment with phenytoin, carbamazepine or barbiturates.
    Shorvon SD; Reynolds EH
    J Neurol Neurosurg Psychiatry; 1982 Jul; 45(7):620-6. PubMed ID: 6288881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of nerve conduction velocity in patients on diphenylhydantoin therapy.
    Mehrotra TN; Srivastava SS; Goel VK; Sood K; Singh VS; Jain AK
    J Assoc Physicians India; 1992 Sep; 40(9):619-20. PubMed ID: 1339187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensory and motor nerve conduction velocity in long-term diphenylhydantoin therapy.
    Xavier de Castro JH; Acosta ML; Sica RE; Guercio N
    Arq Neuropsiquiatr; 1972 Sep; 30(3):215-20. PubMed ID: 4628218
    [No Abstract]   [Full Text] [Related]  

  • 10. Temperature dependence of the toxic effects of phenytoin on peripheral neuromuscular function of the rat tail.
    Romá J; Cuervo AM; Macian F; Raya A; Gallego J; Llopis JE; Romero FJ
    Neurotoxicol Teratol; 1990; 12(6):627-31. PubMed ID: 2255306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral neuropathy in epileptic patients.
    Swift TR; Gross JA; Ward LC; Crout BO
    Neurology; 1981 Jul; 31(7):826-31. PubMed ID: 6264351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor and sensory conduction velocities and electromyographic findings in man before and after carbamazepine treatment.
    Lühdorf K; Nielsen CJ; Orbaek K; Hammerberg PE
    Acta Neurol Scand; 1983 Feb; 67(2):103-7. PubMed ID: 6845974
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of myasthenia gravis associated with long-term phenytoin therapy].
    Ozawa T; Nakajima T; Furui E; Fukuhara N
    Rinsho Shinkeigaku; 1996 Nov; 36(11):1262-4. PubMed ID: 9046861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin neuropathy: structural changes in the sural nerve.
    Ramirez JA; Mendell JR; Warmolts JR; Griggs RC
    Ann Neurol; 1986 Feb; 19(2):162-7. PubMed ID: 3008637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of phenytoin on peripheral nerve function in the rat.
    Marcus DJ; Swift TR; McDonald TF
    Muscle Nerve; 1981; 4(1):48-50. PubMed ID: 7231445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and electrophysiological characteristics of the experimental neuropathy caused by p-bromophenylacetylurea.
    Jakobsen J; Lambert EH; Carlson G; Brimijoin S
    Exp Neurol; 1982 Jan; 75(1):158-72. PubMed ID: 6174359
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies to L-periaxin in sera of patients with peripheral neuropathy produce experimental sensory nerve conduction deficits.
    Lawlor MW; Richards MP; De Vries GH; Fisher MA; Stubbs EB
    J Neurochem; 2002 Nov; 83(3):592-600. PubMed ID: 12390521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bicuculline and picrotoxin as antagonists of gamma-aminobutyrate and neuromuscular inhibition in the lobster.
    Shank RP; Pong SF; Freeman AR; Graham LT
    Brain Res; 1974 May; 72(1):71-8. PubMed ID: 4830478
    [No Abstract]   [Full Text] [Related]  

  • 20. Peripheral neuropathy in long-term diphenylhydantoin therapy.
    Lovelace RE; Horwitz SJ
    Arch Neurol; 1968 Jan; 18(1):69-77. PubMed ID: 4293820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.